Free shipping on all orders over $ 500

 About 13 results found for searched term "PD07" (0.071 seconds)

Cat.No.  Name Target
M1875 PD173074 FGFR
PD173074 is a selective FGFR1 and FGFR3 inhibitor with IC50 values of 5, 21.5, ~100, 17600 and 19800 nM for FGFR3, FGFR1, VEGFR2, PDGFR and c-Src respectively.
M2668 Enrofloxacin Antibiotic
BAY-Vp2674; PD160788
Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis. Enrofloxacin is classified under the second generation quinolone antibiotics, known as ′fluoroquinolones′.
M3287 PD128907 hydrochloride Dopamine Receptor
PD 128907 hydrochloride is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.
M7107 PD 90780 Others
PD 90780 is a inhibits NGF binding to p75 NTR .
M8003 (+)-PD 128,907 hydrochloride Others
Selective D3 dopamine receptor agonist.
M8005 PD 168,077 maleate salt Others
Selective D4 dopamine receptor agonist.
M8045 PD-407824 Others
PD-407824 is a Wee1/Chk1 inhibitor.
M8058 PD-156707 Others
PD-156707 is a selective endothelin receptor (ETA) antagonist.
M9482 PD-168077 maleate Dopamine Receptor
PD-168077 maleate is a potent D4 dopamine receptor agonist (Ki = 8.7 nM), with > 400-fold and > 300-fold selectivity over D2 / D3 subtypes, respectively.
M9776 Darbufelone Prostaglandin Receptor
CI-1004; PD-136095-0073
Darbufelone is a dual inhibitor of cellular PGF2α and LTB4 production, it is also a COX-2 inhibitor potentially for the treatment of rheumatoid arthritis.
M29495 PD 102807  AChR/AChE
PD 102807 is a M4 muscarinic receptor antagonist with an IC50 of 90.7 nM. PD 102807 inhibits M1, M2, M3, M5 muscarinic receptor with IC50s of 6558.7, 3440.7, 950.0, and 7411.7 nM, respectively. Antidyskinetic effect.
M42246 PD-307243 Potassium Channel
PD-307243 is a hERG channel activator.
M42660 PD07 AChR/AChE
PD07 is an orally active AChE inhibitor (IC50: 0.29 μM for hAChE).



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.